Cita APA (7a ed.)

Hebner, C. M., Han, B., Brendza, K. M., Nash, M., Sulfab, M., Tian, Y., . . . Schmitz, U. (2012). The HCV non-nucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase function. Public Library of Science (PLoS).

Cita Chicago Style (17a ed.)

Hebner, Christy M., et al. The HCV Non-nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function. Public Library of Science (PLoS), 2012.

Cita MLA (8a ed.)

Hebner, Christy M., et al. The HCV Non-nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function. Public Library of Science (PLoS), 2012.